-+ 0.00%
-+ 0.00%
-+ 0.00%

Inhibikase Therapeutics announces annual shareholder meeting webcast

PUBT·04/20/2026 20:06:41
Listen to the news
Inhibikase Therapeutics announces annual shareholder meeting webcast
  • Inhibikase Therapeutics scheduled 2026 annual shareholder meeting for June 26, 2026, to be held virtually.
  • Shareholders will vote to elect two Class III directors: Arvind Kush, Dennis Berman.
  • Ballot includes ratification of CohnReznick as independent auditor for fiscal 2026.
  • Items include charter amendment to limit liability for certain officers, subject to stockholder approval.
  • Meeting will also vote on increasing 2020 equity plan share reserve by 3,000,000 shares, executive pay advisory vote, preferred frequency for future pay votes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-163935), on April 20, 2026, and is solely responsible for the information contained therein.